Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006328 · ClinicalTrials.gov registry record
Angiotensin-Converting Enzyme Gene Polymorphism and the Risk of Chronic Allograft Nephropathy
A clinical trial, sponsored by National Center for Research Resources (NCRR).
- Completed
- Registry status
NCT00006328: Completed study, sponsored by National Center for Research Resources (NCRR).
NCT00006328 is a clinical trial that has completed, run by National Center for Research Resources (NCRR). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00006328 has completed, sponsored by National Center for Research Resources (NCRR).
- COMPLETED
- Registry status
Study Summary
This study is intended to help doctors learn about the relationships between specific genetic makeup (gene markers) and the development of chronic rejection. This study is being done to see if there is a relationship between genetic patterns and the development of Chronic Allograft Nephropathy (CAN). Medical scientists also hope to learn more about how genetic differences between people determine their response to a drug or a disease by storing a small blood sample in a special "bank". This sample may be tested at some point in the future in an attempt to better understand the factors that may influence rejection, transplantation outcomes and transplant success rates.
Trial Details
| Field | Value |
|---|
What the finished NCT00006328 record still lists
NCT00006328 is an observational study that tracks outcomes without assigning an intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 0 interventions.
NCT00006328 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00006328 about?
NCT00006328 is a clinical study titled "Angiotensin-Converting Enzyme Gene Polymorphism and the Risk of Chronic Allograft Nephropathy". This study is intended to help doctors learn about the relationships between specific genetic makeup (gene markers) and the development of chronic rejection. This study is being done to see if there is a relationship between genetic patterns and the development of Chronic Allograft Nephropathy (CAN)...
What is the current status of trial NCT00006328?
This trial is currently completed.
Who is sponsoring clinical trial NCT00006328?
This trial is sponsored by National Center for Research Resources (NCRR), which has 94 total clinical trials registered on ClinicalTrials.gov.